ALB and hemophilia A: The frog Alb promoter was used in the clinical trial of the gene therapy drug for hemophilia A–ASC618 (NCT04676048) as part of the minimal synthetic promoter HCB (HNF1-AbpShort-SynO-TSS, 146 bp).